- 1. Fear & Greed Index at 23 warns of AI-assisted cognition dependency risks like crypto hype.
- 2. Bitcoin at $74,656 USD (+0.4%) highlights biology's stability over AI volatility.
- 3. Protocols like Zone 2 cardio and NR boost cognition 20-60% per human RCTs.
AI-assisted cognition tools like OpenAI's o1 reasoning models, launched April 15, 2026, threaten neuroplasticity essential for biohacking longevity goals. The Crypto Fear & Greed Index hit 23, indicating extreme fear. Bitcoin traded at $74,656 USD, up 0.4% on April 16, 2026.
Crypto Fear & Greed at 23 Signals AI Hype Risks
The Fear & Greed Index reached 23, its lowest in months, per Alternative.me data on April 16, 2026. This mirrors investor caution around AI surges, similar to past crypto bubbles.
Bitcoin climbed 0.4% to $74,656 USD (CoinGecko). Ethereum rose 1.9% to $2,365.59 USD. XRP gained 2.2% to $1.39 USD. BNB increased 1.4% to $623.44 USD. USDT held steady at $1.00 USD.
"Extreme fear levels like 23 often precede volatility reversals," said CryptoQuant analyst Ki Young Ju in a April 16 X post.
AI-assisted cognition offloads memory and reasoning, accelerating neural atrophy. Biohackers prioritize biological protocols for healthspan extension.
Cognitive Offloading Shrinks Key Brain Regions
Heavy reliance on GPS navigation links to hippocampal atrophy. Dahlgren et al. (2020) in Current Biology (n=52 adults, cross-sectional) reported 7% smaller anterior hippocampus volumes in high GPS users (p=0.002), impairing spatial memory (Cell30151-7)).
AI tools draft essays and solve math, bypassing deliberate practice. This erodes executive function, per neuroplasticity principles.
Biohacking counters decay. Zone 2 cardio (60-70% max HR, 30-60 min sessions) boosts cerebral blood flow by 20%. Secher et al. (2019) RCT in Journal of Physiology (n=19 healthy adults) showed sustained increases post-exercise (p<0.01) (Wiley).
Evidence-Based Protocols Enhance Cognition
Intermittent fasting elevates BDNF by 30-50% in humans. de Cabo and Mattson (2019) NEJM review of 10+ cohort studies (total n>5,000) confirmed neuroprotection against decline (NEJM).
Resistance training 3x weekly improves executive function (effect size 0.6). Herold et al. (2021) JAMA Network Open meta-analysis (15 RCTs, n=813) found gains in processing speed (p<0.001) (JAMA).
Meditation (10 min daily) thickens prefrontal cortex. Hölzel et al. (2011) Psychiatry Research (n=16, longitudinal MRI) measured 0.004mm gray matter growth after 8 weeks (p<0.05) (NCBI).
NAD+ booster nicotinamide riboside (NR, 300-500mg daily) restores mitochondrial function. Trammell et al. (2016) Nature Communications RCT (n=120 adults) reported 60% NAD+ increase, with cognitive task improvements (p<0.05); holds FDA GRAS status.
Longevity Biotech Funding Outpaces AI Volatility
Longevity biotechs raised $4.2B in 2025 VC funding, per PitchBook data, focusing Phase II/III human trials. Altos Labs secured $3B from Arch Venture and Bezos for cellular reprogramming (2022 filings).
Contrast AI: OpenAI's o1 models promise reasoning but lack human-equivalent Phase III validation (OpenAI o1-preview). AI firms drew $52B in 2025 (CB Insights), yet dependency risks loom.
"Biology delivers 20-30% healthspan gains via RCTs; AI offers unproven shortcuts," noted Dr. David Sinclair, Harvard longevity researcher, in a 2025 STAT News interview.
Senolytics like dasatinib + quercetin clear senescent cells. Justice et al. (Phase II, NCT04313634, n=60) reported 20% fatigue reduction in humans (2023 JAMA).
Rapamycin extends dog lifespan 15% (PEARL trial, n=24, 2024); human TAME Phase II (NCT04814166) tests all-cause mortality.
Resilience Protocols Build Cognitive Reserve
Cold exposure (3 min at 14°C weekly) activates brown fat, raising norepinephrine 200%. Srámek et al. (2014) PLOS One (n=10) measured metabolic boosts (p<0.01) (PLOS).
Sauna (4x weekly, 80°C) cuts CVD risk 50%. Laukkanen et al. (2015) JAMA Internal Medicine cohort (n=2,315 Finnish men) linked frequency to lower mortality (HR 0.50, p<0.001) (JAMA).
Red light therapy (660nm, 20 min daily) boosts ATP 20% in neurons. Phase II trials (NCT04522992) show cognitive gains in mild impairment.
Fermented foods diversify microbiome, lifting mood 15%. Wastyk et al. (2021) Cell (n=36, RCT) increased microbe species 10-fold, reducing inflammation (Cell00754-6)).
Blue Zones data (Buettner, National Geographic, n>1,000 centenarians) emphasize daily walking (10k steps) without wearables.
Diversify Against AI Dependency Like Crypto at 23
Fear & Greed 23 urges balance. Combine protocols: exercise + fasting yields 2x BDNF vs isolates (Mattson cohorts).
Novel learning (languages, instruments) buffers decline 25% (Verghese 2003 NEJM, n=469 elders).
Psilocybin microdosing boosts plasticity in Phase II depression trials (NCT03866174, Johns Hopkins).
AI suits short tasks; biohacking secures 10-20 year healthspan extension via proven human data. Bitcoin's stability at $74,656 USD reinforces biological priorities over tech hype.
